Navigation Links
New licensing agreement could improve treatment options for children living with HIV
Date:7/25/2014

Washington, D.C.-- July 25, 2014 -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the new licensing agreement between the Medicines Patent Pool (MPP) and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate (TAF), a promising new HIV medication. The agreement was announced during the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia.

While TAF is still in Phase III clinical trials, early data suggests it could be a key ingredient in the next generation of first-line fixed-dose treatment options for children living with HIV.

"With only one in four children living with HIV currently getting treatment, we cannot continue to do business as usual," said Charles Lyons, EGPAF president and CEO. "We congratulate MPP and Gilead on this expanded collaboration and their proactive efforts to support countries and populations hardest hit by HIV and AIDS. This is the kind of innovative action that we need now to protect the health of affected children and in order to achieve an AIDS-free generation. "

The license will allow manufacturers in India and China to develop generic versions of TAF for 112 countries that are home to more than 92 percent of people living with HIV in the developing world.

Every day, almost 700 babies are newly infected with HIV, almost all of whom live in sub-Saharan Africa. EGPAF and its affiliates have provided critical HIV care and treatment to more than 2 million individuals, including 160,000 children and enrolled more than 95,000 children on antiretroviral therapy.


'/>"/>
Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. BioPharm Insight Releases Quarterly Licensing Information on Global Drug Development
2. Edison Nation Medical Secures Licensing Agreement with Medline Industries, Inc. for New Hospital Isolation Gown Invented by Nurse to Address Hospital Infections
3. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013
4. Colorado Colorado State Regulators Decide up Licensing Fees and Rules for Upcoming Recreational Pot Business, as reported by PotStores.com
5. OdorNo® Signs Exclusive Agreement with BaseCamp™: Licensing of OdorNo® Technology for BaseCamp™ Odor Barrier Bags™ for Camping, Fishing, Hunting and the Outdoors
6. Amco Agency announce an Immediate Sale or Licensing Opportunity: Fluorescent Lifetime Test / Drug Screening Equipment and Consumables
7. Central Oregon Management Consultant Earns TIGERS Success Series Team Development and Team Effectiveness Certification and Licensing
8. Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive
9. Global food safety research agreement signed by China and UC Davis
10. Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow
11. League of Voluntary Hospitals and Homes and 1199SEIU Reach New Four-Year Collective Bargaining Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... Prophecy concerning this present generation. Yisrayl makes an astounding statement when he says ... He explains that the Bible details the current times so plainly that anyone should ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... will return to the La Gorce Country Club in Miami Beach to host ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... in thought leadership , media relations, content marketing, social media management, corporate ... several clients already in the state and in nearby New Hampshire, Massachusetts and ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Pharma To Market Pty Ltd and Ador Consulting Pte Ltd announce ... of Pharma To Market Pte Ltd, based in Singapore ... their expansion into Asia with the opening ... are delighted to appoint Joelle Chia , former owner of ... based entity. Joelle brings with her an extensive business network throughout ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
Breaking Medicine Technology: